Erratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977)
2017 ◽
Vol 20
(2)
◽
pp. 212-220
◽
2020 ◽
Vol 16
(8)
◽
pp. 128
2011 ◽
Vol 62
(1)
◽
pp. 221-228
◽